A Randomized, Open-label, Phase 2 Trial of Ponatinib in

  • Warlick, Erica (PI)

Project: Research project

Project Details

Description

A Randomized, Open-label, Phase 2 Trial of Ponatinib in Patients with Resistant Chronic Phase Chronic Myeloid Leukemia to Characterize the Efficacy and Safety of a Range of Doses
StatusActive
Effective start/end date8/1/1510/31/20

Funding

  • ARIAD PHARMACEUTICALS, INC

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.